Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab

Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab

Introduction: Myasthenia gravis (MG) is an antibody mediated autoimmune neuromuscular disorder characterized by fatigable muscle weakness. A proportion of myasthenia gravis patients are classified as refractory due to non responsiveness to conventional treatment. This retrospective study was done to...

Full description

Bibliographic Details
Main Authors: Sudulagunta, Sreenivasa Rao, Sepehrar, Mona, Sodalagunta, Mahesh Babu, Settikere Nataraju, Aravinda, Bangalore Raja, Shiva Kumar, Sathyanarayana, Deepak, Gummadi, Siddharth, Burra, Hemanth Kumar
Format: Article
Language:deu
Published: German Medical Science GMS Publishing House 2016-10-01
Series:GMS German Medical Science
Subjects:
myasthenia gravis
refractory
rituximab
Online Access:http://www.egms.de/static/en/journals/gms/2016-14/000239.shtml

Internet

http://www.egms.de/static/en/journals/gms/2016-14/000239.shtml

Similar Items